These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8940081)

  • 1. Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.
    Yokote K; Margolis B; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1996 Nov; 271(48):30942-9. PubMed ID: 8940081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction between Shc and the platelet-derived growth factor beta-receptor.
    Yokote K; Mori S; Hansen K; McGlade J; Pawson T; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1994 May; 269(21):15337-43. PubMed ID: 8195171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
    Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
    Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation.
    Arvidsson AK; Rupp E; Nånberg E; Downward J; Rönnstrand L; Wennström S; Schlessinger J; Heldin CH; Claesson-Welsh L
    Mol Cell Biol; 1994 Oct; 14(10):6715-26. PubMed ID: 7935391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors.
    Eriksson A; Nånberg E; Rönnstrand L; Engström U; Hellman U; Rupp E; Carpenter G; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1995 Mar; 270(13):7773-81. PubMed ID: 7535778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
    Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
    J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells.
    Linseman DA; Benjamin CW; Jones DA
    J Biol Chem; 1995 May; 270(21):12563-8. PubMed ID: 7759503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
    Nishimura R; Li W; Kashishian A; Mondino A; Zhou M; Cooper J; Schlessinger J
    Mol Cell Biol; 1993 Nov; 13(11):6889-96. PubMed ID: 7692233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
    van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
    Pero SC; Oligino L; Daly RJ; Soden AL; Liu C; Roller PP; Li P; Krag DN
    J Biol Chem; 2002 Apr; 277(14):11918-26. PubMed ID: 11809769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis.
    Yokote K; Mori S; Siegbahn A; Rönnstrand L; Wernstedt C; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1996 Mar; 271(9):5101-11. PubMed ID: 8617789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
    Bibbins KB; Boeuf H; Varmus HE
    Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.
    Li W; Nishimura R; Kashishian A; Batzer AG; Kim WJ; Cooper JA; Schlessinger J
    Mol Cell Biol; 1994 Jan; 14(1):509-17. PubMed ID: 8264620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
    Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
    Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
    Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of shc as the primary protein binding to the tyrosine-phosphorylated beta 3 subunit of alpha IIbbeta 3 during outside-in integrin platelet signaling.
    Cowan KJ; Law DA; Phillips DR
    J Biol Chem; 2000 Nov; 275(46):36423-9. PubMed ID: 10964917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.